It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
15 years are enough! ECJ decided on the maximum period of exclusivity of a patent and SPC
-
Patent case: Judgment no. 1289/19 of Valencia Court of Appeals, dated 15 October 2019, Spain
-
Brexit Judgment: R Miller v Secretary of State for Exiting the European Union [2016] EWHC 2768 (Admin)
-
UPC temporarily restricts functions CMS to the benefit of opting out
-
Amended Guidelines on Independence of the Swiss Federal Patent Court became effective on 1 January 2015 – An inspiring model for the UPC?
-
Patent case: CenTrak Inc. v Sonitor Technologies Inc., USA
-
(Indirect) infringement, Chemical Engineering, Extent of Protection, Inventive step, Netherlands, Revocation, Scope of protection, Validity
Glaxo v. Pharmachemie, District Court The Hague (Rechtbank Den Haag), 08 September 2009
-
Irish referendum on Unitary Patent system in 2023 or 2024
-
IP challenges in North Macedonia
-
Compulsory licenses granted by public authorities: an application in the Covid-19 crisis in France? Part 2